Biologics and Biosimilars: Vanguards of Health Care and Antitrust
12 PM EST
Biologics and biosimilars represent one of the most important and fastest-growing corners of healthcare. Join our expert panel as we discuss competition issues involving biologics and biosimilars, including how the regulatory approval framework for biosimilars differs from that of small moleculte generics and the implications of those differences on competition and antitrust causes of action.
Moderator: Randall Weinsten, Federal Trade Commission
Ashley Bass, Covnington & Burling
Michael Carrier, Rutgers Law School
Bruce Leicher, Former SVP and GC at Momenta Pharmaceuticals
Fiona Scott Morton, Yale School of Management
FREE: Antitrust Section Members, Government, Non-profit Employees, Students, and $25 Other Non-Members.
Explore Section benefits or call 1-800-285-2221 to join. To learn more: https://www.americanbar.org/groups/antitrust_law/
The ABA is not seeking CLE credit for this program.
Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.